Apellis Pharmaceuticals I... (APLS)
NASDAQ: APLS
· Real-Time Price · USD
17.33
0.53 (3.15%)
At close: May 29, 2025, 3:32 PM
3.15% (1D)
Bid | 17.32 |
Market Cap | 2.18B |
Revenue (ttm) | 775.84M |
Net Income (ttm) | -223.68M |
EPS (ttm) | -1.8 |
PE Ratio (ttm) | -9.63 |
Forward PE | -28.57 |
Analyst | Hold |
Ask | 17.34 |
Volume | 1,051,283 |
Avg. Volume (20D) | 2,517,247 |
Open | 17.07 |
Previous Close | 16.80 |
Day's Range | 16.65 - 17.48 |
52-Week Range | 16.10 - 43.76 |
Beta | 0.72 |
About APLS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol APLS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for APLS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-5.91%
Apellis Pharmaceuticals shares are trading lower a...
Unlock content with
Pro Subscription
1 month ago
+3.7%
Apellis Pharmaceuticals shares are trading higher after the company announced FDA acceptance, priority review of sNDA for EMPAVELI.

3 weeks ago · seekingalpha.com
Apellis Pharmaceuticals, Inc. (APLS) Q1 2025 Earnings Call TranscriptApellis Pharmaceuticals, Inc. (NASDAQ:APLS ) Q1 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Tracy Vineis – Vice President-Communications Cedric Francois – Co-Founder and ...